Use of beta-blockers, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers to prevent atrial fibrillation

被引：4
|
作者：
Wachtell K. [1 ]
Devereux R.B. [1 ]
Lyle P.A. [1 ]
机构：
[1] Rigshospitalet, Department of Cardiology, The Heart Center, DK-2100 Copenhagen
来源：
Current Cardiology Reports | 2006年 / 8卷 / 5期
关键词：
Amiodarone; Enalapril; Losartan; Valsartan; Ramipril;
D O I：
10.1007/s11886-006-0075-1
中图分类号：
学科分类号：
摘要：
Atrial fibrillation, the most common cardiac arrhythmia in clinical practice, causes significant burden to patients and health care systems worldwide. Attention is being paid to prevention of atrial fibrillation using drugs that retard or prevent atrial fibrosis and arrhythmogenic remodeling, which lead to this arrhythmia. Agents that work through the renin-angiotensin-receptor system, the angiotensin-converting enzyme inhibitors and angiotensin receptor blockers, are showing promise in animal and human studies. Copyright © 2006 by Current Science Inc.
引用
收藏
页码：356 / 364
页数：8
相关论文
共 50 条
  • [31] A retrospective study of angiotensin-converting enzyme inhibitors or beta-blockers to prevent trastuzumab-induced cardiotoxicity
    Sun, K.
    Anand, K.
    Manne, S.
    Xu, X.
    Niravath, M.
    Nicolas, J. C.
    Jones, S. L.
    Patel, T. A.
    Geyer, C.
    Chang, J. C.
    Niravath, P.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S933 - S933
  • [32] The complete reversal effect following angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and beta-blockers after the primary diagnosis of dilated cardiomyopathy
    Liu, Tao
    Zhou, Ping
    Jiang, Xin
    Wang, Na
    Shou, Jialing
    Fang, Yuqiang
    [J]. JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2023, 28 (01):
  • [33] Effect of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on the frequency of post-cardiothoracic surgery atrial fibrillation
    Coleman, Craig I.
    Makanji, Sagar
    Kluger, Jeffrey
    White, C. Michael
    [J]. ANNALS OF PHARMACOTHERAPY, 2007, 41 (03) : 433 - 437
  • [34] Angiotensin converting enzyme inhibitors and angiotensin receptor blockers
    Shrimpton, A. J.
    Walker, S. L. M.
    Ackland, G. L.
    [J]. BJA EDUCATION, 2020, 20 (11) : 362 - 367
  • [35] Increasing the use of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers to prevent diabetic nephropathy
    Christian-Herman, JL
    Fornataro, MP
    Miller, RM
    [J]. DIABETES, 2002, 51 : A211 - A211
  • [36] Effects of antihypertensive agents, alpha receptor blockers, beta blockers, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and calcium channel blockers, on oxidative stress
    Baykal, Y
    Yilmaz, MI
    Celik, T
    Gok, F
    Rehber, H
    Akay, C
    Kocar, IH
    [J]. JOURNAL OF HYPERTENSION, 2003, 21 (06) : 1207 - 1211
  • [37] Association Between Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and Suicide
    Mamdani, Muhammad
    Gomes, Tara
    Greaves, Simon
    Manji, Selina
    Juurlink, David N.
    Tadrous, Mina
    Kennedy, Sidney H.
    Antoniou, Tony
    [J]. JAMA NETWORK OPEN, 2019, 2 (10)
  • [38] Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers in the Treatment of Hypertension
    Benenson, Irina
    [J]. JNP- THE JOURNAL FOR NURSE PRACTITIONERS, 2022, 18 (05): : 586 - 587
  • [39] The Role of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Postangioplasty Restenosis
    Liu, Ying
    Carrey, Zev
    Aronow, Wilbert S.
    Alaie, Daruish
    Petrillo, Richard L.
    Frishman, William H.
    [J]. AMERICAN JOURNAL OF THERAPEUTICS, 2015, 22 (04) : e107 - e114
  • [40] Angiotensin-converting enzyme inhibitors, angiotensin-receptor blockers, and risk of appendicitis
    Mukamal, Kenneth J.
    Ghimire, Sanjay
    Pandey, Rudra
    Fiarman, Gale S.
    Gautam, Shiva
    [J]. ANNALS OF EPIDEMIOLOGY, 2012, 22 (10) : 747 - 750
12345